The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement-Reference-Cited by-同舟云学术

The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement

Published:2021-01 Issue: Volume:100 Page:106480
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Bergstrom Colin P.^ORCID,Dahiya Saurabh,Chen Weina,Zhang Cheng Cheng,Zhu Hong,Yan Jingsheng,Madanat Yazan,Patel Prapti,Vusirkala Madhuri,Ramakrishnan Praveen,Rizvi Syed,Chung Stephen,Awan Farrukh,Anderson Larry D.^ORCID,Collins Robert,Kansagra Ankit

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia;Bisschop;Leukemia,2001

2. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution’s experience;Abbott;Leukemia,2003

3. Central nervous system disease in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group;Johnston;Pediatr. Blood Cancer,2017

4. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children’s Oncology Group study;Johnston;Pediatr. Blood Cancer,2010

5. Acute myeloid leukemia with central nervous system involvement in children: experience from the French protocol analysis ELAM02;Felix;J. Pediatr. Hematol. Oncol.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target;Chinese Medical Journal;2024-07-08

2. Diagnosis and management of adult central nervous system leukemia;Blood Science;2023-05-30

3. LILRB4, an immune checkpoint on myeloid cells;Blood Science;2022-04

4. Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities;Blood Reviews;2021-11

5. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis;Nature Cancer;2021-11